Robust global disease surveillance from WHO and CDC underpins the 88.5% market-implied odds for no new pandemic in 2026, with no novel pathogens exhibiting sustained human-to-human transmission. H5N1 avian flu circulates in wild birds and mammals but shows minimal human cases without efficient spread, while mpox variants remain regionally contained. Post-COVID enhancements in wastewater monitoring, genomic sequencing, and mRNA vaccine platforms have strengthened early detection and response, tempering escalation risks. Experts estimate a 2-3% baseline annual zoonotic spillover probability, but absent acute signals, traders consensus tilts heavily against a 2026 event.
Experimental AI-generated summary referencing Polymarket data · Updated$172,563 Vol.
$172,563 Vol.
$172,563 Vol.
$172,563 Vol.
The resolution source will be official announcements from the World Health Organization.
Market Opened: Dec 1, 2025, 4:37 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Robust global disease surveillance from WHO and CDC underpins the 88.5% market-implied odds for no new pandemic in 2026, with no novel pathogens exhibiting sustained human-to-human transmission. H5N1 avian flu circulates in wild birds and mammals but shows minimal human cases without efficient spread, while mpox variants remain regionally contained. Post-COVID enhancements in wastewater monitoring, genomic sequencing, and mRNA vaccine platforms have strengthened early detection and response, tempering escalation risks. Experts estimate a 2-3% baseline annual zoonotic spillover probability, but absent acute signals, traders consensus tilts heavily against a 2026 event.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions